Assesses tuberous sclerosis complex disease burden across CNS (tubers, SEGA, SEH), pulmonary (LAM), renal (AML, cysts), cardiac (rhabdomyomas), and dermatological manifestations to guide everolimus/sirolimus therapy.
Assesses tuberous sclerosis complex disease burden across CNS (tubers, SEGA, SEH), pulmonary (LAM), renal (AML, cysts), cardiac (rhabdomyomas), and dermatological manifestations to guide everolimus/sirolimus therapy
Each component has a specific meaning:
Note: Interpret the tsc disease burden result against the thresholds and context described above.
Enter the CNS (tubers, SEGA, SEH), pulmonary, renal (AML, cysts) for the scenario you are assessing. Assesses tuberous sclerosis complex disease burden across CNS (tubers, SEGA, SEH), pulmonary (LAM), renal (AML, cysts), cardiac (rhabdomyomas), and dermatological manifestations to guide everolimus/sirolimus therapy. Use the tsc disease burden result to inform your calculation.